N
VTVT icon

Nuveen’s vTv Therapeutics VTVT Stock Holding History

Nuveen’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,621
Closed -$2.1M – 3540
2021
Q1 		$2.1M Buy
18,621
+17,586
+1,699% +$1.73M ﹤0.01% 2590
2020
Q4 		$77K Hold
1,035
– – ﹤0.01% 3245
2020
Q3 		$74K Buy
1,035
+263
+34% +$23.1K ﹤0.01% 3230
2020
Q2 		$69K Buy
+772
New +$76.2K ﹤0.01% 3172

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen's VTVT Position: Q2 2021 in Review

Nuveen sold out of vTv Therapeutics (VTVT) in Q2 2021, closing a stake of 18,621 shares — an estimated $2.1M sold.

Nuveen first reported a position in VTVT in Q2 2020 and held it in 4 quarters. The position peaked at $2.1M in Q1 2021. 42 funds tracked by Wall St. Rank hold VTVT as of Q2 2021.

  • Nuveen reported no remaining vTv Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Nuveen sold 18,621 vTv Therapeutics shares in Q2 2021, an estimated $2.1M.
  • Nuveen first reported a position in vTv Therapeutics in Q2 2020 and held it in 4 quarters.
  • Nuveen's vTv Therapeutics position peaked at $2.1M in Q1 2021.
  • 42 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2021.

Based on Nuveen's 13F filing for Q2 2021, filed 16 Aug 2021.